CENTURY THERAPEUTICS INC (IPSC) Stock Analyst Earnings Estimates
NASDAQ:IPSC - Nasdaq - US15673T1007 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.2M | 2.235M -57.02% | 6.589M 194.81% | 111.36M 1,590.09% | -100.00% | 10.883M | 39.77M 265.43% | 75.225M 89.15% | ||||
| EBITDA YoY % growth | -115.39M -26.62% | -112.137M 2.82% | -120.506M -7.46% | -143.942M -19.45% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -123.83M -30.51% | -125.181M -1.09% | -133.81M -6.89% | -27.939M 79.12% | -149.413M -434.78% | -154.382M -3.33% | -186.66M -20.91% | 46.92M 125.14% | 271.32M 478.26% | 650.76M 139.85% | N/A | |
| Operating Margin | -2,381.35% | -5,600.94% | -2,030.81% | -25.09% | N/A | N/A | N/A | N/A | 2,493.06% | 1,636.31% | N/A | |
| EPS YoY % growth | -2.28 30.47% | -2.29 -0.44% | -1.63 28.82% | -0.28 83.00% | -1.44 -419.63% | -1.45 -0.59% | -1.31 9.86% | 0.09 107.03% | 1.53 1,566.67% | N/A | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.39 -2.00% | -0.39 -5.22% | -0.40 6.70% | -0.40 -144.93% | -0.49 -26.32% | -0.49 -25.76% | -0.50 -24.58% |
| Revenue Q2Q % growth | -100.00% | -100.00% | -100.00% | -100.00% | 1.02M | 1.02M | 1.02M |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -34.84M 0.46% | -34.116M 1.94% | -34.649M -5.14% | -37.026M -149.92% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 0.89 297.78% | 0.06 | 0.83 | 1,486.45% |
| Q4 2024 Q2Q % growth | -0.43 33.85% | -0.43 | 0.00 | 0.10% |
| Q3 2024 Q2Q % growth | -0.37 32.73% | -0.46 | 0.09 | 19.03% |
| Q2 2024 Q2Q % growth | -0.38 32.14% | -0.47 | 0.09 | 19.26% |
| Q1 2024 Q2Q % growth | -0.45 15.09% | -0.51 | 0.06 | 12.12% |
| Q4 2023 Q2Q % growth | -0.65 -18.18% | -0.57 | -0.08 | -14.97% |
| Q3 2023 Q2Q % growth | -0.55 -3.77% | -0.52 | -0.03 | -5.20% |
| Q2 2023 Q2Q % growth | -0.56 -3.70% | -0.56 | 0.00 | -0.88% |
| Q1 2023 Q2Q % growth | -0.53 19.70% | -0.53 | 0.00 | 0.73% |
| Q4 2022 Q2Q % growth | -0.55 -129.17% | -0.60 | 0.05 | 9.01% |
| Q3 2022 Q2Q % growth | -0.53 -10.42% | -0.61 | 0.08 | 12.65% |
| Q2 2022 Q2Q % growth | -0.54 72.02% | -0.53 | -0.01 | -2.60% |
| Q1 2022 Q2Q % growth | -0.66 | -0.46 | -0.20 | -43.00% |
| Q4 2021 Q2Q % growth | -0.24 | -0.49 | 0.25 | 50.72% |
| Q3 2021 Q2Q % growth | -0.48 | -0.41 | -0.07 | -17.65% |
| Q2 2021 Q2Q % growth | -1.93 | -0.43 | -1.50 | -354.11% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 109.164M 12,667.72% | 50.541M | 58.623M | 115.99% |
| Q4 2024 Q2Q % growth | 4.173M 1,457.09% | 956.76K | 3.216M | 336.16% |
| Q3 2024 Q2Q % growth | 791K 434.46% | 2.064M | -1.273M | -61.68% |
| Q2 2024 Q2Q % growth | 771K 678.79% | 1.97M | -1.199M | -60.86% |
| Q1 2024 Q2Q % growth | 855K -50.29% | 1.287M | -432K | -33.57% |
| Q4 2023 Q2Q % growth | 268K -48.46% | 1.874M | -1.606M | -85.70% |
| Q3 2023 Q2Q % growth | 148K -93.33% | 1.185M | -1.037M | -87.51% |
| Q2 2023 Q2Q % growth | 99K -92.93% | 1.164M | -1.065M | -91.49% |
| Q1 2023 Q2Q % growth | 1.72M 62.26% | 1.336M | 384K | 28.74% |
| Q4 2022 Q2Q % growth | 520K | 2.009M | -1.489M | -74.12% |
| Q3 2022 Q2Q % growth | 2.22M | 1.151M | 1.069M | 92.88% |
| Q2 2022 Q2Q % growth | 1.4M | 975.559K | 424.441K | 43.51% |
| Q1 2022 Q2Q % growth | 1.06M | 5.1M | -4.04M | -79.22% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -5.56% | 0% | 74.21% |
| Revenue | N/A | -100% | 0% | 81.13% |